Thorsten Sieß
Chief Executive Officer bei ABIOMED, INC.
Profil
Gegenwärtig ist Thorsten Sie Chief Technology Officer & Vice President bei ABIOMED, Inc. und Co-Geschäftsführer bei ABIOMED Europe GmbH (einer Tochtergesellschaft von ABIOMED, Inc.). Er ist auch im Vorstand von Arterica, Inc. Dr. Sie hat an der RWTH Aachen promoviert und einen Hochschulabschluss erworben.
Aktive Positionen von Thorsten Sieß
| Unternehmen | Position | Beginn |
|---|---|---|
| ABIOMED, INC. | Chief Executive Officer | - |
ABIOMED Europe GmbH
 ABIOMED Europe GmbH Medical SpecialtiesHealth Technology ABIOMED Europe GmbH manufactures and markets micro blood pumps. These systems have been designed to provide a temporary solution while the patient is waiting for heart surgery or a heart transplant (bridge to operation or bridge to transplant). It is also used to stabilize the patient until a decision can be made regarding long-term therapy such as a long-term cardiovascular support system or an artificial heart. The company was founded in 1998 and is headquartered in Aachen, Germany. | Chief Executive Officer | - |
Arterica, Inc.
 Arterica, Inc. Miscellaneous Commercial ServicesCommercial Services Arterica, Inc. operates as a biotechnology company. The company is headquartered in Santa Rosa, CA. | Director/Board Member | - |
Ehemalige bekannte Positionen von Thorsten Sieß
| Unternehmen | Position | Ende |
|---|---|---|
Impella Cardiosystems AG
 Impella Cardiosystems AG Medical SpecialtiesHealth Technology Impella Cardiosystems AG develops, manufactures, and markets minimally invasive cardiovascular support systems. The company is based in Aachen, Germany. The German company was founded by Thorsten Sieß. | Founder | - |
Ausbildung von Thorsten Sieß
| RWTH Aachen University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
ABIOMED, Inc.
 ABIOMED, Inc. Medical SpecialtiesHealth Technology ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA. | Health Technology |
ABIOMED Europe GmbH
ABIOMED Europe GmbH Medical SpecialtiesHealth Technology ABIOMED Europe GmbH manufactures and markets micro blood pumps. These systems have been designed to provide a temporary solution while the patient is waiting for heart surgery or a heart transplant (bridge to operation or bridge to transplant). It is also used to stabilize the patient until a decision can be made regarding long-term therapy such as a long-term cardiovascular support system or an artificial heart. The company was founded in 1998 and is headquartered in Aachen, Germany. | Health Technology |
Impella Cardiosystems AG
Impella Cardiosystems AG Medical SpecialtiesHealth Technology Impella Cardiosystems AG develops, manufactures, and markets minimally invasive cardiovascular support systems. The company is based in Aachen, Germany. The German company was founded by Thorsten Sieß. | Health Technology |
Arterica, Inc.
Arterica, Inc. Miscellaneous Commercial ServicesCommercial Services Arterica, Inc. operates as a biotechnology company. The company is headquartered in Santa Rosa, CA. | Commercial Services |
